Is it financially beneficial for hospitals to prevent nosocomial infections?

Table 3 Insurer payment to hospital during primary hospitalization: matched comparisons between patients with healthcare acquired infection and their controls

	Cases	Controls	Difference	p-value
	USD
	Mean	Mean (min, max)^c	Mean (min, max)^c	Mean (min, max)^c
CLABSI^a	24,673	10,065 (3281,24,673)	14,608 (0,21,392)	< 0.001 (< 0.001, 0.18)
CDI^a	11,468	6038 (2795,9895)	5430 (1573,8673)	0.02 (< 0.001, 0.53)
SSI ^b	9819	9793 (9749,9792)	26 (−40, 70)	0.77 (0.54, 0.54)

^a Hospitalization-days × cost per day
^b Diagnosis-related group (DRG)
^c min, mean of matched control patients with minimum resource consumption; max, mean of matched control patients with maximum resource consumption
USD US Dollar, CLABSI central-line associated bloodstream infection, CDI Clostridium difficile infection, SSI surgical site infection

ISSN: 1472-6963